Neptune Wellness Solutions Inc. - stock earnings
NEPT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -13.4 million USD | 5.7 million USD |
| 2023Q3 | -655009 USD | 6.4 million USD |
| 2023Q2 | -27.1 million USD | 12.4 million USD |
| 2023Q1 | -19.6 million USD | 9.0 million USD |
| 2022Q4 | 656042 USD | 12.2 million USD |
| 2022Q3 | -31.1 million USD | 12.1 million USD |
| 2022Q2 | -31.0 million USD | 11.2 million USD |
| 2022Q1 | -26.9 million USD | 9.8 million USD |
| 2021Q4 | -15.0 million USD | 14.7 million USD |
| 2021Q3 | -11.1 million USD | 12.5 million USD |
| 2021Q2 | -16.9 million USD | 10.1 million USD |
| 2021Q1 | -37.1 million USD | 3.6 million USD |
| 2020Q4 | -57.6 million USD | 3.2 million USD |
| 2020Q3 | -14.5 million USD | 19.1 million USD |
| 2020Q2 | -8.4 million USD | 8.3 million USD |
| 2020Q1 | -27.7 million USD | 6.7 million USD |
| 2019Q4 | 4.3 million USD | 7.0 million USD |
| 2019Q3 | -15.8 million USD | 4.9 million USD |
| 2019Q2 | -4.9 million USD | 3.3 million USD |
| 2019Q1 | -9.2 million USD | 4.2 million USD |
| 2018Q4 | -2.7 million USD | 4.8 million USD |
| 2018Q3 | -2.3 million USD | 5.4 million USD |
| 2018Q2 | -3.1 million USD | 3.9 million USD |
| 2018Q1 | -3.7 million USD | 5.4 million USD |
| 2017Q4 | 3.8 million USD | 5.8 million USD |
| 2017Q3 | 15.3 million USD | 5.5 million USD |
| 2017Q2 | -1.2 million USD | 5.0 million USD |
| 2017Q1 | 3.6 million USD | 5.3 million USD |
| 2016Q4 | -887049 USD | 8.6 million USD |
| 2016Q3 | 8.1 million USD | 9.2 million USD |
| 2016Q2 | -1.7 million USD | 8.7 million USD |
| 2016Q1 | -1.4 million USD | 4.3 million USD |
| 2015Q4 | -1.3 million USD | 4.0 million USD |
| 2015Q3 | -1.4 million USD | 3.3 million USD |
| 2015Q2 | -3.6 million USD | 2.2 million USD |
| 2015Q1 | -1.1 million USD | 3.7 million USD |
| 2014Q4 | -7.9 million USD | 3.5 million USD |
| 2014Q3 | -11.4 million USD | 2.4 million USD |
| 2014Q2 | -4.4 million USD | 3.5 million USD |
| 2014Q1 | -8.0 million USD | 4.0 million USD |
| 2013Q4 | -8.3 million USD | 4.1 million USD |
| 2013Q3 | -4.3 million USD | 5.9 million USD |
| 2013Q2 | -213837 USD | 4.5 million USD |
| 2013Q1 | -220482 USD | 4.5 million USD |
| 2012Q4 | -11.7 million USD | 7.1 million USD |
| 2012Q3 | -4.0 million USD | 8.3 million USD |
| 2012Q2 | -2.2 million USD | 5.7 million USD |
| 2012Q1 | -2.2 million USD | 5.4 million USD |
| 2011Q4 | -480709 USD | 4.9 million USD |
| 2011Q3 | -1.1 million USD | 4.3 million USD |
| 2011Q2 | -887491 USD | 4.5 million USD |
| 2011Q1 | 1.8 million USD | 4.3 million USD |
| 2010Q4 | 1.8 million USD | 4.3 million USD |
| 2010Q3 | 250761 USD | 3.8 million USD |
| 2010Q2 | -43634 USD | 4.2 million USD |
| 2010Q1 | -45649 USD | 4.4 million USD |
| 2009Q4 | 1.8 million USD | 3.4 million USD |
| 2009Q3 | -1.8 million USD | 1.2 million USD |
| 2009Q2 | -1.1 million USD | 2.3 million USD |
| 2009Q1 | -868706 USD | 1.6 million USD |
| 2008Q4 | -462080 USD | 1.8 million USD |
| 2008Q3 | -563261 USD | 2.2 million USD |
| 2008Q2 | -1.2 million USD | 3.0 million USD |
| 2008Q1 | -1.5 million USD | 2.1 million USD |
| 2007Q4 | -1.6 million USD | 2.2 million USD |
| 2007Q3 | -1.5 million USD | 2.2 million USD |
| 2007Q2 | -987736 USD | 2.0 million USD |
| 2007Q1 | -336485 USD | 2.1 million USD |
| 2006Q4 | -337702 USD | 1.5 million USD |
| 2006Q3 | -231920 USD | 1.3 million USD |
| 2006Q2 | -931801 USD | 1.6 million USD |
| 2006Q1 | 781845 USD | 1.4 million USD |
| 2005Q4 | -280805 USD | 1.1 million USD |
| 2005Q3 | -282279 USD | 1.3 million USD |
| 2005Q2 | -332695 USD | 892197 USD |
| 2005Q1 | -230938 USD | 866128 USD |
| 2004Q4 | -351828 USD | 825632 USD |
| 2004Q3 | -234468 USD | 685041 USD |
| 2004Q2 | -675339 USD | 7880 USD |
| 2004Q1 | -410555 USD | 344399 USD |
| 2003Q4 | -442040 USD | 568043 USD |
| 2003Q3 | -428098 USD | 344504 USD |
| 2003Q2 | -741926 USD | 342449 USD |
| 2003Q1 | -240358 USD | ? USD |
| 2002Q4 | -540953 USD | 42349 USD |
| 2002Q3 | -309062 USD | 42334 USD |
| 2002Q2 | -347123 USD | ? USD |
| 2002Q1 | -287957 USD | ? USD |
| 2001Q4 | -238193 USD | ? USD |
| 2001Q3 | -205456 USD | ? USD |
| 2001Q2 | -124791 USD | ? USD |
| 2001Q1 | -188074 USD | ? USD |
| 2000Q4 | -135560 USD | ? USD |
| 2000Q3 | -52391 USD | ? USD |
| 2000Q2 | -53249 USD | ? USD |
NEPT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -60.4 million USD | 52.6 million USD |
| 2022 | -74.9 million USD | 48.7 million USD |
| 2021 | -123.2 million USD | 35.4 million USD |
| 2020 | -42.9 million USD | 20.9 million USD |
| 2019 | -17.3 million USD | 18.2 million USD |
| 2018 | 13.6 million USD | 21.5 million USD |
| 2017 | 4.8 million USD | 32.4 million USD |
| 2016 | -5.8 million USD | 17.4 million USD |
| 2015 | -22.1 million USD | 11.9 million USD |
| 2014 | -15.1 million USD | 17.6 million USD |
| 2013 | -16.5 million USD | 25.5 million USD |
| 2012 | -4.6 million USD | 19.3 million USD |
| 2011 | 542980 USD | 17.6 million USD |
| 2010 | -1.4 million USD | 11.9 million USD |
| 2009 | -3.8 million USD | 8.2 million USD |
| 2008 | -2.4 million USD | 7.4 million USD |
| 2007 | -697387 USD | 5.4 million USD |
| 2006 | -1.2 million USD | 3.4 million USD |
| 2005 | -2.1 million USD | 1.4 million USD |
| 2004 | -1.9 million USD | 1.3 million USD |
| 2003 | -1.1 million USD | ? USD |
| 2002 | -479424 USD | ? USD |
| 2001 | -77066 USD | ? USD |
| 2000 | -83507 USD | ? USD |
NEPT
Price: $0.20
52 week price:
Earnings Per Share: -44.13 USD
P/E Ratio: -0.01
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 58877
Ebitda: 20.7 millionMarket Capitalization: 906408
Average Dividend Frequency: 1